Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-07-15 Sale | 2020-07-17 5:23 pm | ARENA PHARMACEUTICALS INC | ARNA | Cabell Christopher EVP, Head of R&D, and CMO | 13,000 | $68 | $884,000 | 47,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-18 Option Award | 2023-05-22 9:15 pm | N/A N/A | Zura Bio Ltd | ZURA | Cabell Christopher CMO & Head of R&D | 162,060 | $0 | 162,060 (Direct) | View |
Ownership | 2023-03-21 7:33 pm | N/A 2023-03-15 | Zura Bio Ltd | ZURA | Cabell Christopher EVP and CMO | 0 | $0 | 270,100 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 4:05 pm | N/A 2033-01-26 | Pulmatrix Inc. | PULM | Cabell Christopher Director | 1,700 | $0 | 1,700 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 09:36 am | N/A 2032-01-27 | Pulmatrix Inc. | PULM | Cabell Christopher Director | 22,100 | $0 | 22,100 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 9:45 pm | N/A 2031-01-28 | Pulmatrix Inc. | PULM | Cabell Christopher Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-30 4:01 pm | N/A 2022-01-03 | ARENA PHARMACEUTICALS INC | ARNA | Cabell Christopher EVP, Head of R&D, and CMO | 2,500 | $0 | 6,401 (Direct) | View |
| 2020-11-25 Tax Withholding | 2020-11-30 4:01 pm | N/A N/A | ARENA PHARMACEUTICALS INC | ARNA | Cabell Christopher EVP, Head of R&D, and CMO | 1,099 | $65.5 | 6,401 (Direct) | View |
| 2020-07-15 Exercise | 2020-07-17 5:23 pm | N/A 2024-11-15 | ARENA PHARMACEUTICALS INC | ARNA | Cabell Christopher EVP, Head of R&D, and CMO | 13,000 | $0 | 47,000 (Direct) | View |
| 2020-07-15 Exercise | 2020-07-17 5:23 pm | N/A N/A | ARENA PHARMACEUTICALS INC | ARNA | Cabell Christopher EVP, Head of R&D, and CMO | 13,000 | $26.28 | 47,000 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-25 9:46 pm | N/A 2030-06-23 | Pulmatrix Inc. | PULM | Cabell Christopher Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-06-12 Option Award | 2020-06-16 7:25 pm | N/A 2027-06-12 | ARENA PHARMACEUTICALS INC | ARNA | Cabell Christopher EVP, Head of R&D, and CMO | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2020-06-16 7:23 pm | N/A 2024-11-15 | ARENA PHARMACEUTICALS INC | ARNA | Cabell Christopher EVP, Head of R&D, and CMO | 0 | $0 | 212,500 (Direct) | View |